505 related articles for article (PubMed ID: 3027441)
1. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of Burkitt's lymphoma cells.
Preud'homme JL; Dellagi K; Guglielmi P; Vogler LB; Danon F; Lenoir GM; Valensi F; Brouet JC
IARC Sci Publ; 1985; (60):47-64. PubMed ID: 3864747
[TBL] [Abstract][Full Text] [Related]
3. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
4. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.
Favrot MC; Philip I; Philip T; Portoukalian J; Doré JF; Lenoir GM
J Natl Cancer Inst; 1984 Oct; 73(4):841-7. PubMed ID: 6592381
[TBL] [Abstract][Full Text] [Related]
5. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
[TBL] [Abstract][Full Text] [Related]
7. Ecto-5'-nucleotidase. I. Expression in human normal and neoplastic lymphoid cell lines representing sequential stages of B-cell differentiation.
SenGupta S; Hibi T; MacKay A; Markovic V; Stein LD; Sigal N; Gelfand EW; Chechik BE
J Natl Cancer Inst; 1984 Nov; 73(5):1075-80. PubMed ID: 6092765
[TBL] [Abstract][Full Text] [Related]
8. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
10. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
Berger R; Bernheim A
C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
[TBL] [Abstract][Full Text] [Related]
11. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
12. Establishment of Epstein-Barr virus-negative diffuse large cell lymphoma cell line with an 8;22 chromosomal translocation.
Ichinose I; Nakano S; Ohshima K; Mitsugi K; Anzai K; Shida T; Niho Y
Cancer Res; 1991 Oct; 51(19):5392-7. PubMed ID: 1913659
[TBL] [Abstract][Full Text] [Related]
13. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
15. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
17. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
19. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.
Campana D; Janossy G; Bofill M; Trejdosiewicz LK; Ma D; Hoffbrand AV; Mason DY; Lebacq AM; Forster HK
J Immunol; 1985 Mar; 134(3):1524-30. PubMed ID: 3918103
[TBL] [Abstract][Full Text] [Related]
20. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
